Hoʻokumu ʻia ka Idrinol a me Mildronate ma muli o ka hana a me ka hydronate meldonium, kahi mea hoʻohuiʻenehana synthe o gamma-butyrobetaine. I.e. ʻo ia nā lāʻau lapaʻau i hāpai ʻia no ka hoʻomaikaʻi ʻana i nā kaʻina metabolic.
Ke koho i kahi lāʻau lapaʻau e pono ai, pono ʻoe e familiarize iā ʻoe iho ʻaʻole me ka hoʻonohonoho wale ʻana i nā lāʻau, akā, me nā mea hōʻike o lākou, contraindications a me nā hopena ʻaoʻao. Akā hiki i kahi kauka ke kuhikuhi i kahi lāʻau lapaʻau ma ke kumu o kahi loiloi a me nā hopena o nā hōʻike. ʻAʻole kuhi ʻia ka lāʻau lapaʻau iho.
Nā hiʻohiʻona o Idrinol
Hōʻike ʻia ka lāʻau lapaʻau e kahi kiʻekiʻe o ka bioavailability - 78-80%. I ka manawa like, ua koke koke ʻia ia i loko o ke koko, a i hoʻokahi hola ʻoi aku kona kiʻekiʻe. Hoʻopili nui ʻia ia e nā keiki.
Hoʻokomo koke ʻia ka Idrinol i loko o ke koko, a ma hope o hoʻokahi hola ka lōʻihi o kona paʻa ʻana.
Pono ʻoe e makaʻala i ka wā e hoʻohana ana i nā lāʻau lapaʻau e kōkua ai i ke kahe koko, me ka diuretics a me nā bronchodilators.
Nā ʻano o ka hoʻokuʻu - capsules a i ʻole injection. E like me ka palapala hoʻopuni, hoʻopuka ʻia ka lāʻau lapaʻau me kahi hapa o 250 mg. Mea hana - Sotex PharmFirma CJSC, i hoʻopaʻa ʻia ma Rusia.
Hoʻohui ʻia Mildronate
ʻAʻole kēia he lāʻau hou. Ua kūkulu mua ʻia i ka 1970s. i Lukia. I ka mea mua i hoʻohana ʻia ma ka lāʻau mālama lāʻau, a me nā mea hiki i ke mālama ʻana i ka atherosclerosis a me CHF i ʻike iki i hope. I kēia lā, ke hana ʻia nei ka lāʻau lapaʻau e ka hui Latvian JSC Grindeks.
ʻO ke ʻano nui o ka hoʻokuʻu ʻana he 10% ʻōnaehana inikua a me nā kīleʻa gelatin paʻakikī. I loko ʻo kahi keʻokeʻo keʻokeʻo.
Hoʻohālikelike o Idrinol a me Mildronate
ʻO nā lāʻau ʻelua ke ʻano like me nā ʻano like. ʻO ka mea nui ka meldonium. ʻOiai ma muli o ka hōʻea ʻana o ka ʻOkiō, ua ʻike ʻia e nā mea he nui i ka doping, ua ākea ka nui o nā ʻano lāʻau lapaʻau like ʻole. Hiki ke kuhikuhi i nā mea hōʻolo e hoʻomaikaʻi i ke kahe o ke koko, e hoʻonui i ka ʻoluʻolu o ke kino i ke kaumaha. Hāʻawi ka lāʻau lapaʻau i ka ikehu o ke kino a kāwili i ka pūnaehana nūhou.
Mālama i nā lāʻau ʻelua i ka hana puʻuwai.
No ka mea e pili ana nā lāʻau lapaʻau i nā mea like, e hana like lākou - hoʻomaikaʻi lākou i ka hana cardiac, hoʻomaʻamaʻa i ke kahe koko i nā hihia o ka hana palau. Hoʻokomo ʻia nā lāʻau no ka atherosclerosis, maʻi maʻi.
ʻO ka hoʻohana ʻana o ka mea hana like i ka hoʻopili ʻana, a ma ka hoʻohālikelike like ʻana, alakaʻi ʻia i ka ʻike ʻana ʻaʻole wale nō nā ʻōmole like ʻole no ka hoʻohana ʻana, akā like pū kekahi mau contraindications a me nā hopena ʻaoʻao.
Ka mea maʻamau?
ʻO kahi hiʻohiʻona maʻamau no ka lāʻau lapaʻau ka hiki ʻana o ka meldonium. Loaʻa ka hope hope i kekahi hopena o ka lāʻau lapaʻau, ka mea:
- Hoʻihoʻi hou o ka lawe ʻana mai o ka oxygen a hoʻonui i kona hoʻohana ʻana i nā pūʻola;
- ka hopena cardioprotective (hoʻopili maikaʻi i ka puʻuwai naʻau);
- ka hoʻonui ʻana i ke kaha i ke kino kino a noʻonoʻo;
- ka hoʻokumu 'ana o ka hana kūlohelohe kūlohelohe;
- ka hōʻemi ʻana o nā hōʻailona o ke kaumaha kino a me ke kaumaha;
- ka hoʻololi ʻana i ka hopena o ka hoʻopiʻi post-infarction.
Hoʻohana ʻia ʻo Meldonium i ka mālama ʻana i ka maʻi diabetes, akā ʻo ka ʻāpana o ka ʻoihana paʻakikī. He hopena maikaʻi ia i ka metabolism o nā lipids a me ka glucose, ua hōʻoia ʻia e kēia mau noi ʻana i hoʻokele ʻia i nā makahiki 2000. Eia kekahi, kōkua nā mākau meldonium e hakakā i ka polyneuropathy maʻi.
Ke lawe nei i nā lāʻau lapaʻau, hoʻomaikaʻi ka hoʻomanaʻo ʻana, loaʻa kahi hopena maikaʻi i ka hoʻomohala kognitive o kahi kanaka.
I ka hoʻopōʻino ischemic poino i ka myocardium, lohi ʻo meldonium i ke kaʻina o ka necrosis kiko a hoʻomaʻamaʻa i nā hana hoʻoponopono. Ma ka nāwaliwali o ka naʻau paʻakikī, hoʻomaikaʻi hou ka hana myocardial. Eia kekahi, ʻoi aku ka maikaʻi o nā poʻe maʻi e hoʻomanawanui i ka hana pilikino, hōʻemi ʻia kā lākou helu o ka hoʻouka ʻana a angina.
Hoʻopau like nā hopena ʻaoʻao. I kēia:
- dyspepsia (hoʻomehana, luaʻi, puʻuwai);
- nā puʻuwai kūloko puʻuwai, me ka tachycardia;
- psychomotor agitation;
- nā maʻi kūlohelohe (hōʻeha o ka ʻili, hyperemia, urticaria, a i ʻole nā ʻano ʻano ʻē aʻe);
- nā hoʻololi i ke koko.
Akā ua hoʻomanawanui maikaʻi nā lāʻau ʻelua. Ua hōʻike ʻia nā haʻawina ma nā mea maʻi me ka maʻi cerebrovascular maʻi, ʻo nā maʻi maʻi maʻi ʻē aʻe, ʻaʻohe ʻaʻohe o ka wehe ʻana o ka hoʻomākaukau ʻana o ka meldonium ma muli o ka hiki ʻana o nā hopena ʻaoʻao.
ʻO nā hōʻailona no ka hoʻohana ʻana o Idrinol a me Mildronate i hoʻohālikelike maoli ʻia:
- ka wā o ka wā kūpono - e hoʻoulu ai i nā hana hoʻoponopono;
- maʻi ʻeha coronary, me ka angina pectoris, pre-infarction condition a me ka infarction pololei;
- retinopathy me ka maʻi mellitus a i ʻole ka maʻi hypertension;
- pilikia paʻa kino (CHF);
- ke kino kino, ʻoi aku hoʻi i nā mea pāʻani loea;
- nā hōʻeha a me nā kakuhi cerebrovascular i hoʻokumu ʻia e nā maʻi a me nā maʻi ʻoi ʻole ka paʻa o ka lolo (ua hoʻokomo ʻia nā lāʻau i ka regimen therapy paʻakikī);
- hōʻeha maʻi waʻaila (ʻo ia hoʻi kahi mahele o ka hoʻomaʻamaʻa paʻakikī);
- huahua
I kekahi manawa ua kauoha ʻia nā lāʻau lapaʻau no ka maʻi maʻi o ke kaʻi i loko o nā moku o ka retina, ka hele ʻana o ka thrombosis, a me nā hemorrhages.
ʻO nā hoʻohālikelike ma Mildronate a me Idrinol aneane like ʻole. E pili ana kēia:
- hoʻonui mahihuahua intracranial;
- hypersensitivity e meldonium a me nā mea kōkua o ka lāʻau.
ʻO nā haʻawina holoʻokoʻa e hōʻoia ai i ka palekana o ka hoʻohana ʻana i ka hoʻomākaukau meldonium no nā wahine hāpai ʻaʻole i mālama ʻia. No laila, ʻaʻole i kauoha ʻia ʻo Mildronate a me Idrinol no lākou. Pili ka like o ko lākou hana no nā keiki a me nā ʻōpio i lalo o 18 makahiki o kona mau makahiki.
Ua kuhikuhi ʻia ke ʻano o ke mālama ʻana e ke kauka, i ka ʻike ʻana i nā ʻano o ka maʻi, ka makahiki o ka mea maʻi, kona ʻano maʻamau, etc. Nui ka hilinaʻi ma ke ʻano o ka hoʻokele o ka lāʻau lapaʻau. ʻO kahi laʻana, ma ka ophthalmology, ua hoʻohana ʻia kahi hoʻonā kaha hoʻonā i nā maʻi neʻe o ka maʻi i ka retina. ʻO ka lōʻihi loa o ka mālamaʻana i kēia hihia he 10 mau lā.
Ma kahi o ka hana o ka puʻuwai maʻi pākuhi, ʻelua mau lāʻau me ka mālama nui, e hoʻomau ʻia ka hoʻoholo hope loa me ke kauka.
Poke? I? O man?
Hōʻike nā hana kūleʻa i nāʻokoʻa ʻole ma waena o Mildronate a me Idrinol. Kokoke lāua i ka pāpaʻi a me nā contraindications. A ʻo ka hopena ʻili, ʻo lākou pū kekahi. ʻO ka ʻokoʻa ka mea like he Mildronate ka ʻokoʻa, akā hiki i ke kumu no ka hōʻeha a me ka pupuhi.
Aia nā noiʻi e hōʻike ana me hoʻohana ʻia ʻo Mildronate ʻaʻole e hoʻopau wale i nā maʻi kaulia ma hope o kahi hōʻeha, akā ke hoʻomaikaʻi pū i nā kūlana kaumaha ʻole e hui pū ʻia me kēia maʻi. ʻAʻole pili ka lāʻau lapaʻau i nā pilikia o ka hana ʻana a me ka hoʻopilikia cognitive wale nō, akā nō hoʻi i ka pilia-psycho-naʻau. Pēlā ke hoʻonui nei i ka hana pono o ka papahana hoʻoponopono. No Idrinol, ʻaʻohe haʻawina i hana ʻia.
Aia ia ka hapa?
ʻO ke kumu kūʻai o Mildronate mai 300 mau rubles no ka pāʻana o 250 mg i 650 rubles no nā kapika 500 mg. Iʻoi aku ka waiwai o Idrinol. No kahi ʻāpana me 250 mg capsules o ka mea ikaika, e uku ka mea maʻi e pili ana i ka 200 rubles.
He aha ka mea maikaʻi i idrinol a i ʻole Mildronate?
ʻAʻole hiki ke pane pololei i ka nīnau o ka mea e ʻoi aku ka maikaʻi, ʻo Idrinol a ʻo Mildronate. Ua aʻo ʻia nā ʻelua lāʻau, ua like ka like me ka like ʻole, a like me ke ʻano like a ʻike maikaʻi ʻia nā mea maʻi.
He hoʻohālikelike nā lāʻau lapaʻau. Eia kekahi, ua hana ʻia ma Rusia, no ka laʻana, Cardionate. Akā ʻo Idrinol a me Mildronate i noʻonoʻo ʻia ʻoi aku ka maikaʻi. ʻO ka manaʻo i ka ʻoiʻo Idrinol, ʻoi aku ka maʻalahi.
Nā Hōʻike Hoʻomaʻi
ʻO Svetlana, 42 makahiki, ʻo Ryazan: "Ua hōʻike lākou i ka maʻi type 2. Ua kuhikuhi ke kauka iā Mildronate, ma waena o nā lāʻau lapaʻau ʻē aʻe. Ua hoʻomau ʻia ka maikaʻi, ʻaʻohe alerine ma laila. Hiki iaʻu ke ʻōlelo i nā hoʻomaikaʻi ʻana i nā ʻano o ka hihiʻo."
ʻO Vladislav, 57 makahiki, ʻo Moscow: "Ua mālama lākou i ka hale maʻi me ka maʻi pre-infarction, he nui nā lāʻau lapaʻau i kauoha ʻia, me Mildronate.
Zinaida, 65 makahiki, Tula. "Ua ʻōlelo ʻia mai ʻo Idrinol no ka maʻi puʻukū coronary. He lāʻau lapaʻau maikaʻi, ʻaʻohe hopena o ka hopena, a loaʻa kahi hoʻomaikaʻi maikaʻi."
Ua aʻo ʻia nā ʻelua lāʻau, ua like ka like me ka like ʻole, a like me ke ʻano like a ʻike maikaʻi ʻia nā mea maʻi.
ʻLelo a nā kauka e pili ana i ka Idrinol a me Mildronate
ʻO Vladimir, cardiologist, Moscow: "No ka hiki ʻole o ka puʻuwai naʻau ke kuhikuhi aku nei au iā Mildronate, he maikaʻi ia, ʻae maikaʻi ʻia. Aia nō nā noiʻi e hoʻopale maikaʻi ana i ka kūlana noʻonoʻo, hoʻomaikaʻi pū ka naʻau."
Ekaterina, neurologist, Novosibirsk: "Ke kuhikuhi nei wau iā Mildronate no nā hanana cerebrovascular. Akā hiki iā ʻoe ke hoʻololi i ka lāʻau me Idrinol - ʻoi aku ka maʻalahi."
